Search

everythinglearnresearchcommunity

for

Search:↓

Some leukemia treatments can cause skin reactions similar to keratosis pilaris.

Baricitinib shows promise for severe alopecia areata but isn't a cure and has side effects.

No cure exists for alopecia areata, and treatments are personalized.

Chronic inflammatory skin diseases are caused by disrupted interactions between skin cells and immune cells.

Hair loss can be caused by cancer, treatments, or skin conditions, and trichoscopy helps diagnose it.

Bisphenol-A (BPA) increases connections between brain cells and boosts their activity, but it blocks the effects of a male hormone on brain cell plasticity.

Cancer treatments often cause hair loss, and more research is needed to prevent and treat it.

Any drug can cause skin reactions, but antibiotics, NSAIDs, and psychotropic drugs are more common, with some reactions being life-threatening.

Ginsenoside Rg1 protects mouse skin from UVB damage and helps control inflammation.

Higher levels of certain proteins in the blood are linked to more severe patchy alopecia areata.

Minoxidil and finasteride effectively treat hair loss.

Deucravacitinib improves symptoms and reduces inflammation in Lichen Planopilaris.

Topical tofacitinib is a safe and effective treatment for autoimmune skin disorders.

IL-12/23 inhibitors are more effective and have fewer common side effects than anti-TNF alpha for treating psoriasis.

Hedgehog pathway inhibitors could be effective in treating melanoma.

New treatments for alopecia areata show promise, but standardized guidelines are needed.

Blocking IL-17a can improve age-related smell loss in mice.

Pharmacists play a crucial role in safe medication use and interdisciplinary collaboration is key to reducing antimicrobial resistance.

The enzyme steroid sulfatase is linked to breast cancer and other conditions, and inhibitors are being developed for treatment.

Hidradenitis Suppurativa has genetic links, with certain gene mutations more common in patients and a third of cases having a family history.

Baricitinib and its combination with lonafarnib improve fat cell formation in certain genetic disorders.

Topical ruxolitinib may help some skin conditions but needs more research for alopecia areata.

Baricitinib is effective for severe alopecia areata with manageable side effects, mainly upper respiratory infections.

Ritlecitinib shows promise for hair regrowth in alopecia areata patients.

The immune processes causing VKH and vitiligo are similar in dogs and humans.

Ritlecitinib is effective and safe for treating severe alopecia areata in people aged 12 and older.

JAK1 inhibitors can help reduce itchiness in atopic dermatitis.

Specific immune cells and pathways contribute to hair follicle inflammation and hair loss, suggesting potential treatments for lichen planopilaris.

Pine bark extract helps mice grow hair by reducing inflammation and boosting growth factors.

Silybum marianum flower extract may help increase hair growth and decrease hair loss.